Question

What is the recovery time after stem cell therapy for Primary Immunodeficiency?

HSCT can require prolonged admission, immune recovery, infection precautions, revaccination and long surveillance. It is not comparable with recovery after an outpatient infusion. Follow the specialist transplant plan and seek urgent care for fever or new infection symptoms.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Primary Immunodeficiency

Evidence and eligibility are diagnosis-, genotype-, donor- and centre-specific. HSCT may require conditioning and carries infection, graft failure, graft-versus-host disease and organ-toxicity risks; some disorders instead use immunoglobulin, antimicrobial, targeted immune or gene-based treatment. The NIAID GATA2-deficiency factsheet illustrates diagnosis-specific use of HSCT. It cannot validate a generic placental, stromal or exosome product.

Am I a candidate? → · Primary Immunodeficiency: full overview → · Primary Immunodeficiency cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information